The safety of oncobloc
ONCOBLOC is derived from proprietary raw ingredients (ONCOBLOC Standardised Novel CME+ SLS-161) approved by the relevant authorities in Singapore, with over 7 years of safety experience.
The key active ingredient in ONCOBLOC is being studied by leading scientists around the world and give some of the most promising therapeutic results.
ONCOBLOC is compliant with Singapore Health Sciences Authority (HSA) Heavy Metal & Microbiological Safety Standards.
Tested on a batch by batch basis.
Over 175 voluntary safety tests including analytical assessment by the Singapore HSA Pharmaceutical Laboratory have been conducted to ensure ONCOBLOC safety profile is in compliance with Singapore healthcare product safety Standards.
Unlike many medicines and health supplement products, ONCOBLOC has no known side effects and no known contraindications.
Safety assessment Certificate of Analysis (COA) issued by Singapore-based SAC-SINGLAS accredited independent laboratories.
Copyright © 2017 - 2021 Singapore Link Sciences Pte Ltd. All rights reserved.
ONCOBLOC is a registered trade mark of Singapore Link Sciences Pte Ltd.
References
The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice.
Terms of Use  |  Privacy Policy